The funding will enable the company in conducting Phase II human clinical trials for its potential drug candidate for ...

Ahammune Biosciences, a clinical-stage therapeutics company focused on developing new treatments for skin diseases, has ...

In addition to vitiligo, Mini also works with cancer survivors, helping to reconstruct areolas post-mastectomy, and individuals with burn scars or surgical marks. Her approach is deeply personal, ...

Biotech startup Ahammune Biosciences has raised $5 Mn (about INR 41 Cr) in its Series A round led by pi Ventures.

China Medical System Holdings Limited (the “Company”, together with its subsidiaries, the “Group” or “CMS”) is pleased to announce that on September 24, 2024, the New Drug Application (NDA) for ...

Multiple Late-Breaking Data Presentations from Incyte’s Dermatology Portfolio will be Featured at the EADV 2024 Congress ...

The biotech startup will use the funds to assist its Phase II human clinical trials for its drug candidate for vitiligo.

Patients with vitiligo may significantly improve the effectiveness of a commonly used light therapy — by nearly twofold— by ...

Vitiligo is a skin condition that can affect infants as young as 3 months old. However, it is rare for an infant to be born with vitiligo. Vitiligo is an autoimmune disease that can run in families.

Vitiligo is a skin condition that’s little understood and it often takes a long time to diagnose, but now a new treatment could help to cure it. It currently affects around 70 million people around ...

Krrish Sanjanwala and Pranith Surapaneni became best friends in sixth grade. Now as seniors at Blue Valley Northwest High ...